The tumor microbiome and why it may unlock the next advancement in cancer treatment

12 Aug 2020

Written by Daniel Spakowicz and Pannaga Malalur (The Ohio State University, OH, USA)

For researchers Immuno-oncology Opinion Preclinical research and trials

When treating a patient’s cancer, it might be best to consider more than just the human cells. At the Ohio State University Comprehensive Cancer Center – Arthur G. James Cancer Hospital and Richard J. Solove Research Institute (OSUCCC – James; OH, USA), our research has led us to an intriguing new possibility: by understanding a person’s microbiome, we may be able to tailor treatment and better predict patient outcomes. The human microbiome is the composition of bacterial communities that reside on and within the human body. We have ever-increasing evidence of the influence of the microbiome in health, disease, immunity...